Zuzana Tóthová

12.8k total citations · 5 hit papers
47 papers, 8.4k citations indexed

About

Zuzana Tóthová is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Zuzana Tóthová has authored 47 papers receiving a total of 8.4k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 15 papers in Hematology and 9 papers in Oncology. Recurrent topics in Zuzana Tóthová's work include Acute Myeloid Leukemia Research (10 papers), FOXO transcription factor regulation (9 papers) and Genomics and Chromatin Dynamics (6 papers). Zuzana Tóthová is often cited by papers focused on Acute Myeloid Leukemia Research (10 papers), FOXO transcription factor regulation (9 papers) and Genomics and Chromatin Dynamics (6 papers). Zuzana Tóthová collaborates with scholars based in United States, Slovakia and United Kingdom. Zuzana Tóthová's co-authors include David E. Root, Ian C. P. Smith, Meagan E. Sullender, Mudra Hegde, John G. Doench, Katherine Donovan, Herbert W. Virgin, Jennifer Listgarten, Emma W Vaimberg and Robert C. Orchard and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Zuzana Tóthová

46 papers receiving 8.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9

2016 2.6k citations John G. Doench, Nicolò Fusi et al. Nature Biotechnology profile →
FoxOs Are Critical Mediators of Hematopoietic Stem Cell Resistance to Physiologic Oxidative Stress

2007 1.2k citations Zuzana Tóthová, Ramya Kollipara et al. Cell profile →
Rational design of highly active sgRNAs for CRISPR-Cas9–mediated gene inactivation

2014 1.2k citations John G. Doench, Ella Hartenian et al. Nature Biotechnology profile →
FoxOs Are Lineage-Restricted Redundant Tumor Suppressors and Regulate Endothelial Cell Homeostasis

2007 859 citations Ji-Hye Paik, Ramya Kollipara et al. Cell profile →
The Retinoblastoma Binding Protein RBP2 Is an H3K4 Demethylase

2007 336 citations Zuzana Tóthová, D. Gary Gilliland et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zuzana Tóthová United States	23	6.5k	1.1k	929	850	709	47	8.4k
Lihua Julie Zhu United States	54	6.8k 1.0×	383 0.4×	790 0.9×	656 0.8×	454 0.6×	165	9.3k
José M.P. Freije Spain	47	6.1k 0.9×	541 0.5×	1.6k 1.8×	475 0.6×	443 0.6×	98	9.2k
Noboru Motoyama Japan	36	5.1k 0.8×	497 0.5×	1.8k 1.9×	1.8k 2.2×	346 0.5×	63	7.6k
Robert Latek United States	17	5.4k 0.8×	496 0.5×	936 1.0×	1.2k 1.4×	124 0.2×	31	7.6k
William Biggs United States	27	6.0k 0.9×	224 0.2×	601 0.6×	712 0.8×	705 1.0×	33	8.1k
Bruce M. Paterson United States	33	5.9k 0.9×	916 0.8×	2.4k 2.6×	820 1.0×	185 0.3×	56	8.7k
Ivan Topisirović Canada	52	7.7k 1.2×	300 0.3×	960 1.0×	1.0k 1.2×	141 0.2×	111	9.6k
Homayoun Vaziri Canada	19	4.0k 0.6×	364 0.3×	1.2k 1.3×	933 1.1×	1.1k 1.6×	25	8.4k
Diane C. Fingar United States	33	6.2k 1.0×	195 0.2×	932 1.0×	981 1.2×	170 0.2×	49	8.7k
Christian Beauséjour Canada	25	5.1k 0.8×	140 0.1×	998 1.1×	1.1k 1.2×	572 0.8×	57	7.5k

Countries citing papers authored by Zuzana Tóthová

Since Specialization

Citations

This map shows the geographic impact of Zuzana Tóthová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zuzana Tóthová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zuzana Tóthová more than expected).

Fields of papers citing papers by Zuzana Tóthová

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zuzana Tóthová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zuzana Tóthová. The network helps show where Zuzana Tóthová may publish in the future.

Co-authorship network of co-authors of Zuzana Tóthová

This figure shows the co-authorship network connecting the top 25 collaborators of Zuzana Tóthová. A scholar is included among the top collaborators of Zuzana Tóthová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zuzana Tóthová. Zuzana Tóthová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wong, Waihay J., Rebecca L. Zon, Caleb Ho, et al.. (2025). Somatic mutations in STAG2 are associated with separated megakaryocyte nuclear lobes in myelodysplastic syndromes. Blood Advances. 9(20). 5283–5288.

Tóthová, Zuzana, et al.. (2025). Cohesin mutations and chromatin changes in cancer. International Journal of Cancer. 158(2). 368–381. 1 indexed citations

Anczuków, Olga, Frédéric H.‐T. Allain, Brittany Angarola, et al.. (2024). Steering research on mRNA splicing in cancer towards clinical translation. Nature reviews. Cancer. 24(12). 887–905. 8 indexed citations

Wheeler, Emily C., Benjamín Martín, Melanie Donahue, et al.. (2024). Splicing modulators impair DNA damage response and induce killing of cohesin-mutant MDS and AML. Science Translational Medicine. 16(728). eade2774–eade2774. 17 indexed citations

Tóthová, Zuzana, Mangesh Bhide, Andrej Kováč, et al.. (2023). Differentially Expressed Genes Induced by Erythropoietin Receptor Overexpression in Rat Mammary Adenocarcinoma RAMA 37-28 Cells. International Journal of Molecular Sciences. 24(10). 8482–8482. 1 indexed citations

Bondeson, Daniel P., Thomas C. Atack, Nolan Bick, et al.. (2022). Systematic profiling of conditional degron tag technologies for target validation studies. Nature Communications. 13(1). 5495–5495. 19 indexed citations

Jann, Johann-Christoph & Zuzana Tóthová. (2021). Cohesin mutations in myeloid malignancies. Blood. 138(8). 649–661. 26 indexed citations

Ji, Hye Young, Kai Yan, Qian Zhu, et al.. (2021). Inner nuclear protein Matrin-3 coordinates cell differentiation by stabilizing chromatin architecture. Nature Communications. 12(1). 6241–6241. 26 indexed citations

Tóthová, Zuzana, et al.. (2021). STAT5 as a Key Protein of Erythropoietin Signalization. International Journal of Molecular Sciences. 22(13). 7109–7109. 35 indexed citations

10.

Tóthová, Zuzana, et al.. (2021). The Role of PI3K/AKT and MAPK Signaling Pathways in Erythropoietin Signalization. International Journal of Molecular Sciences. 22(14). 7682–7682. 62 indexed citations

11.

Lesch, Bluma J., Zuzana Tóthová, Elizabeth A. Morgan, et al.. (2019). Intergenerational epigenetic inheritance of cancer susceptibility in mammals. eLife. 8. 40 indexed citations

12.

Tóthová, Zuzana & Benjamin L. Ebert. (2017). Doubling Down on Mutant RAS Can MEK or Break Leukemia. Cell. 168(5). 749–750. 2 indexed citations

13.

Elf, Shannon, Nouran S. Abdelfattah, Edwin Chen, et al.. (2016). Mutant Calreticulin Requires Both Its Mutant C-terminus and the Thrombopoietin Receptor for Oncogenic Transformation. Cancer Discovery. 6(4). 368–381. 189 indexed citations

14.

Puram, Rishi V., Monika S. Kowalczyk, Carl G. de Boer, et al.. (2016). Core Circadian Clock Genes Regulate Leukemia Stem Cells in AML. Cell. 165(2). 303–316. 195 indexed citations

15.

Doench, John G., Nicolò Fusi, Meagan E. Sullender, et al.. (2016). Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nature Biotechnology. 34(2). 184–191. 2646 indexed citations breakdown →

16.

Doench, John G., Ella Hartenian, Daniel B. Graham, et al.. (2014). Rational design of highly active sgRNAs for CRISPR-Cas9–mediated gene inactivation. Nature Biotechnology. 32(12). 1262–1267. 1157 indexed citations breakdown →

17.

Sykes, Stephen M., Lars Bullinger, Rukh Yusuf, et al.. (2011). Akt/foxo signaling pathway enforces the differentiation blockade in myeloid leukemias. Experimental Hematology. 39(8). 1 indexed citations

18.

Sykes, Stephen M., Steven Lane, Lars Bullinger, et al.. (2011). AKT/FOXO Signaling Enforces Reversible Differentiation Blockade in Myeloid Leukemias. Cell. 146(5). 697–708. 217 indexed citations

19.

Cornejo, Melanie, Stephen M. Sykes, Cristina Lo Celso, et al.. (2009). A Regulatory Network Between Notch and AKT Signaling Pathways Differentially Controls Megakaryocyte Development From Hematopoietic Stem or Committed Progenitor Cells.. Blood. 114(22). 384–384. 1 indexed citations

20.

Paik, Ji-Hye, Ramya Kollipara, Gerald Chu, et al.. (2007). FoxOs Are Lineage-Restricted Redundant Tumor Suppressors and Regulate Endothelial Cell Homeostasis. Cell. 128(2). 309–323. 859 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact